Week 8 Flashcards

1
Q

Viruses

A

Sub-microscopic, obligate intracellular parasites

With no cell nucleus, organelles or cytoplasm

That only replicate inside a living host cell using host metabolic machinery and
ribosomes to form components that can be assembled into virions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Virus Particle (or Virion)

A

DNA or RNA (single or double stranded)
And a protein coat or capsid (+/- envelope)

This is the extracellular form that enables a virus to be transmitted from one host
cell to another and is metabolically inert

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classification of Viruses

A

Shape (symmetry)

Type of nucleic acid (Baltimore classification)

Whether they have an envelope

What they infect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Viruses are either naked or enveloped

A

Envelopes are membranous structures surrounding the nucleocapsid and are common for animal viruses. The envelope is a lipid bilayer (derived from the
host cell membrane) and has mostly virus-encoded proteins (usually
glycoproteins) embedded in it.

In the case of an enveloped virus, symmetry refers to the nucleocapsid
inside the virus and not the whole virion shape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Genetic Classification (Baltimore)

A

Class I: The double-stranded DNA viruses, Herpesvirus
Class II: The single-stranded DNA viruses, Parvovirus
Class III: The double-stranded RNA viruses, Rotavirus
Class IV: The single stranded coding (+) sense RNA viruses, Poliovirus
Class V: The single stranded anti-coding (-) sense RNA viruses, Influenza virus
Class VI: The single stranded (+) sense RNA viruses using DNA intermediate, Retroviruses
Class VII: The double stranded DNA viruses using RNA intermediate, Hepatitis B virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

General features of viral replication

A
  1. Attachment
  2. Penetration
  3. Synthesis of nucleic acid and protein
  4. Assembly and packaging
  5. release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Virus Receptors

A

These receptors carry out normal functions for the cell but the virus exploits
these receptors for its own advantage (attachment and penetration). These
receptors determine which cell types can be infected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outcomes of viral infection

A

Transformation of normal cells
lytic infection
persistent infection
latent infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Human Immunodeficiency Virus

A

HIV belongs to the Lentivirus genus of the family Retroviridae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HIV: transmission

A

HIV is transmitted through:
• Sexual contact (any type of unprotected sexual contact)
• Blood (e.g. sharing needles, blood transfusion)
• Mother-to-child (vertical transmission)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HIV: Early during infection there may be a flu-like illness

A

• Fever, headache, tiredness, enlarged lymph nodes, occurring 1-2 months post exposure, lasting 1-4 weeks
• Highly infectious at this time, the infected individual may not be sero-positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HIV: Asymptomatic period

A

• Lasts from months to >10 years
• Virus is still actively multiplying and infectious; T cell numbers are slowly decreasing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HIV: AIDS

A

AIDS:
• CD4 T cells decrease to <200/mm3 (healthy adults have >1000)
• Opportunistic infections occur (e.g. organisms that do not normally cause disease in healthy people)
• If untreated, the average time to death without treatment is 11 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does HIV cause disease?

A

• CD4+ T-cells are key to the immune response by stimulating other immune cells, such as
macrophages, B-cells, and CD8+ cytotoxic T-cells, to fight infection
• During the acute phases of the infection, HIV may eliminate more than half of the host’s gut resident
CD4+ T cells which express CCR5
• As a result, “microbial translocation” may occur with leakage of gut microbes and their products
across the tight epithelial barrier and into circulation leading to inflammation and pathogenesis
• Peripheral CD4+ T cells are also infected resulting in HIV turnover and the depletion of CD4+ T-cells
over time
• The depletion of CD4+ T cells causes immune deficiency and increased susceptibility to infection by a
range of pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Opportunistic Diseases in AIDS

A

• Kaposi’s Sarcoma - cancer of the cells lining blood vessels characterised by purple
patches on the skin surface - caused by human herpesvirus 8 (HHV8)
• Pneumocystis carinii pneumonia
• Mycobacterium spp infections e.g. tuberculosis
• Histoplasmosis
• Candiadiasis
• Cytomegalovirus (CMV) disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Influenza

A

Is an enveloped, negatively-sensed RNA virus with a segmented genome
Virions can appear spherical or filamentous

17
Q

Influenza Virus Types

A

Types A, B, C and D
Most disease in humans is caused by Influenza A followed by Influenza B
Influenza C can cause mild illness in humans but not epidemics, while Influenza D
primarily affects animals, in particular, cattle

18
Q

Influenza virus replication (in depth)

A

Influenza enters the host cell by HA binding to sialic
acid on glycoproteins on the host cell.
The host cell endocytoses the virus, which then fuses
its envelope with the endosomal membrane.
The nucleocapsid is released into the cytoplasm, then
travels to the host nucleus where primary transcription
of the viral genes by the viral RNA polymerase occurs.
Once the viral mRNAs are transcribed, they are exported
out of the nucleus to the cytoplasm and are translated by
host cell ribosomes to synthesize new viral proteins
Newly synthesized viral polymerase and nucleoproteins proteins are imported back into the nucleus to
increase the rate of viral replication.

19
Q

Influenza virus replication (simplified)

A

Attachment (adsorption)
Penetration
Uncoating
Viral protein synthesis
Viral nucleic acid replication
Virus assembly
Viral release

20
Q

Influenza symptoms and incubation

A

The incubation period is 1-4 days.
Patients are infectious from the day before symptoms begin until approximately 5 days after onset.

SYMPTOMS INCLUDE:
high fever, myalgia headache, malaise cough,
sore throat, rhinitis

21
Q

Influenza antivirals

A

Neuraminidase (NA) inhibitors such as Tamiflu block the ability of NA to cleave Haemagglutin (HA).

22
Q

Antigenic drift

A

The virus can mutate and make new antigenic variants of
HA and NA (antigenic drift).

23
Q

Influenza Virus Nomenclature

A

Virus
type

Place of
isolation

Host of
isolation

Isolate
number

Year of
isolation

HA and NA
Subtype

24
Q

Global impact of Pandemic Influenza

A

• 1918 “Spanish Flu” (H1N1): approx 50 million deaths est. (CDC)
• 1957 “Asian Flu” (H2N2): approx 1.1 million deaths est. (CDC)
• 1968 “Hong Kong Flu” (H3N2): approx 1 million deaths est. (CDC)
• 2009 “Swine Flu” (H1N1): 151,700-575,400 deaths est (CDC)
Seasonal influenza
290,000 to 650,000 respiratory
deaths worldwide annually (WHO)

25
Influenza vaccine
there are three influenza vaccine production technologies approved by the FDA in the USA Egg-based Flu Vaccines - candidate vaccine viruses (CVVs) are grown in fertilized hen’s eggs and incubated for several days to allow the viruses to replicate - fluid containing the virus is harvested from the eggs - the vaccine viruses are then inactivated, and the virus antigen is purified for use in flu shots Cell-based Flu Vaccines Recombinant Flu Vaccines
26
Seasonal influenza vaccination
Multi-valent vaccine To protect against FluA and FluB Updated annually
27
Possible Factors in the Emergence of New Viruses
Viral mutation and adaptation Human demographics and behaviour Cultivation of infected livestock Economic development and change in land use International travel Climate and weather
28
SARS
Severe Acute Respiratory Syndrome
29
Human SARS-CoV Epidemiology
6 November 2002: Outbreak commenced in the Guangdong Province of China
30
Human SARS-CoV
SARS-CoV is a Coronavirus Crown like appearance Corona = Crown (Latin) Large (60-220nm), enveloped, positive-stranded RNA virus Primarily infects epithelial cells of the respiratory tract and gastrointestinal tract but can replicate in many cell types Commonly associated with upper respiratory disease
31
Human SARS-CoV Transmission
- Close contact with infected person who can contaminate the air, when coughing or sneezing, with droplets containing the virus. Transmission may also occur after direct or indirect contact with respiratory secretions, faeces or animal reservoir
32
Human SARS-CoV Incubation
From 2-10 days
33
Human SARS-CoV Symptoms
-Starts with high fever (> 38oC), headache, discomfort and body aches -After 2-7 days, dry unproductive cough that can lead to hypoxia -Many patients develop pneumonia
34
Human SARS-CoV Contagious period
Appears to commence at the onset of symptoms
35
main cause of Influenza disease in humans
Most influenza disease in humans is caused by Influenza A followed by Influenza B
36
Largest pandemic before COVID
COVID-19 represents the largest pandemic since the H1N1 “Spanish Flu” pandemic of 1918/1919 in terms of number of cases and mortalities worldwide